JSAM
ONC

J. Safra Asset Management’s BeOne Medicines Ltd ONC Stock Holding History

J. Safra Asset Management’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.13K Sell
11
-1
-8% -$295 ﹤0.01% 572
2026
Q1 		$3.56K Sell
12
-10
-45% -$3.24K ﹤0.01% 528
2025
Q4 		$6.68K Buy
22
+12
+120% +$3.93K ﹤0.01% 390
2025
Q3 		$3.41K Hold
10
– – ﹤0.01% 339
2025
Q2 		$2.42K Buy
10
+1
+11% +$245 ﹤0.01% 344
2025
Q1 		$2.45K Buy
+9
New +$2.1K ﹤0.01% 322

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

J. Safra Asset Management's ONC Position: Q2 2026 in Review

J. Safra Asset Management reduced its BeOne Medicines Ltd (ONC) stake by 8.3% in Q2 2026, selling an estimated $295 and leaving 11 shares worth $3.13K. The position accounts for ﹤0.01% of the portfolio, ranked #572.

J. Safra Asset Management first reported a position in ONC in Q1 2025 and has held it in 6 quarters since. The position peaked at $6.68K in Q4 2025. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • J. Safra Asset Management held 11 shares of BeOne Medicines Ltd worth $3.13K as of Q2 2026.
  • J. Safra Asset Management sold 1 BeOne Medicines Ltd share in Q2 2026, an estimated $295.
  • BeOne Medicines Ltd made up ﹤0.01% of J. Safra Asset Management's portfolio in Q2 2026, its #572 holding.
  • J. Safra Asset Management first reported a position in BeOne Medicines Ltd in Q1 2025 and has held it in 6 quarters since.
  • J. Safra Asset Management's BeOne Medicines Ltd position peaked at $6.68K in Q4 2025.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on J. Safra Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.